Natco Pharma Share Price
(NATCOPHARM)
Check the latest share price of Natco Pharma, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
₹883.3
as on 04:01PM, 29 Apr 2025
NSE
Natco Pharma Performance
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
₹874.5Day's Price Range₹900.352 Week's Low
52 Week's High
₹726.852-Week Price Range₹1,639
| Returns % | |
| 1 Month Return | -3.12 % |
| 3 Month Return | -36.49 % |
| 1 Year Return | -21.06 % |
| Market Stats | |
| Previous Close | ₹884.15 |
| Open | ₹888.30 |
| Volume | 6.16L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹13,889.97Cr |
Natco Pharma Fundamentals & Key Indicators
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹13,889.97 Cr
Return on Equity (ROE)
2.54
Return on capital employed (ROCE)
2.77
P/B Ratio
3.3
Dividend Yield
0.59
EPS (TTM)
9.32
Sector
Pharmaceuticals
How to invest in Natco Pharma
Investing in Natco Pharma is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Natco Pharma or NATCOPHARM on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Natco Pharma or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Natco Pharma with just a few clicks!
Natco Pharma Valuation
Track how the P/E of Natco Pharma has moved over time to understand valuation trends.
Natco Pharma in the last 5 years
Lowest (11.76x)
November 2, 2023
Today (12.43x)
December 15, 2023
Industry (58.33x)
December 15, 2023
Highest (90.32x)
April 6, 2022
Today’s Price to Earnings Ratio: 12.43x
Analysts Recommendation on Natco Pharma
Get updated buy, sell, and hold recommendations by analysts on Natco Pharma.
based on 12 analysts
41.67%
Buy
33.33%
Hold
25.00%
Sell
41.67% of analysts recommend a 'HOLD' rating for Natco Pharma. Average target of ₹831.67
Source: S&P Global Market Intelligence
Analysts Forecast on Natco Pharma
Get share price movements and forecasts by analysts on Natco Pharma.
Natco Pharma price forecast by 12 analysts
Upside of7.24%
High
₹1125
Target
₹831.67
Low
₹480
Natco Pharma target price ₹831.67, a slight upside of 7.24% compared to current price of ₹883.3. According to 12 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Natco Pharma revenue growth forecast
Expected growth rate Q1, FY2025:50.91%
Forecast
Actual
Including amortisation and stock based compensations
Natco Pharma EPS growth forecast
EPS estimate Q1, FY2025:86.76%
Forecast
Actual
Source: S&P Global Market Intelligence
Natco Pharma Financials
Get the annual and quarterly financial summary of Natco Pharma, including revenue, profit, loss and more.
Natco Pharma Index Inclusions
Natco Pharma Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Natco Pharma.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 48.84% | 0.00 | |
| Foreign Institutions | 11.91% | 0.00 | |
| Mutual Funds | 8.5% | 0.00 | |
| Retail Investors | 23.87% | 0.00 | |
| Others | 6.88% | 0.00 |
Natco Pharma vs Peers
Compare market cap, revenue, PE, and other key metrics of Natco Pharma with its industry peers.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹13,889.97 Cr | 5.98% | 0.55 | NA | NA | |
| BUY | ₹63,424.92 Cr | 22.06% | 0.55 | NA | NA | |
| BUY | ₹87,426.64 Cr | 31.24% | 0.59 | NA | NA | |
| HOLD | ₹46,605.29 Cr | 17.26% | 0.55 | NA | NA | |
| BUY | ₹28,250.05 Cr | 30.32% | 0.64 | NA | NA |
Natco Pharma News & Key Events
Latest news and events at one place to help you take investing decisions in Natco Pharma.
Natco Pharma Sees Surge in Trading Volume - 24 Apr, 2025
On April 24, 2025, Natco Pharma Ltd experienced a significant trading volume of 144.27 lakh shares, a 34.05 times increase over its two-week average. The stock rose by 8.94% to Rs. 920.00, indicating strong investor interest.Natco Pharma Updates on Risdiplam and Q3 Results - 08 Apr, 2025
Natco Pharma reported a decline in Q3 FY25 revenue and net profit. The company plans to launch Risdiplam at Rs 15,900, pending court clarity. Legal updates led to a 3% rise in stock price.Natco Pharma Shares Drop Amid Tariff Concerns - 04 Apr, 2025
Natco Pharma shares fell 5% to ₹794.75 as investor sentiment soured after President Trump warned of aggressive pharmaceutical tariffs. The stock's decline reflects concerns over potential scrutiny under U.S. trade laws, impacting the company's significant U.S. revenue.Natco Pharma Shares Surge on U.S. Tariff Exemption - 03 Apr, 2025
Natco Pharma shares rose 5.07% to ₹847.45 after the U.S. exempted Indian generics from new tariffs. With 70% of revenue from the U.S., Natco stands to benefit significantly.Natco Pharma Targets ₹2000 Cr Profit Amid Challenges - 30 Mar, 2025
Natco Pharma aims for ₹1,800 to ₹2,000 crore PAT in FY25 and FY26 despite a 37.41% revenue decline in Q3FY25. The company plans to expand globally and launch key oncology products, while facing price erosion in Revlimid. Recent trading saw a 3% drop in share price.Delhi HC Halts Natco Pharma's Risdiplam Launch - 26 Mar, 2025
The Delhi High Court has instructed Natco Pharma to pause the launch of its generic Risdiplam until April 2 due to a patent dispute with Roche.
Insights on Natco Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 26.87% to 27.29% in Mar 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, NATCOPHARM stock has moved up by 5.3%
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 124.6%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 51.1% return, outperforming this stock by 63.3%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 1.92% to 1.85% in Mar 2025 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 49.62% to 49.56% in Mar 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 677.3 Cr → 133.0 Cr (in ₹), with an average decrease of 80.4% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 17.94% to 17.49% in Mar 2025 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 1.43K Cr → 651.1 Cr (in ₹), with an average decrease of 54.6% per quarter
About Natco Pharma
Revenue: ₹1,362.60Cr as on June 2024 (Q2 24)
Net Profit: ₹668.50Cr as on June 2024 (Q2 24)
Listing date: 27 Dec, 1995
Chairperson Name: G S Murthy
| Organisation | Natco Pharma |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Indian Mutual Funds that own Natco Pharma
Check out the Mutual Funds with significant holdings in Natco Pharma.
Futures and Options
View the latest movement in Natco Pharma Futures & Options, including strike prices, expiry dates, and percentage changes.
FAQs
What is Natco Pharma Ltd price today?
Natco Pharma Ltd share price today stands at ₹883.3, Open: ₹888.3, Previous Close: ₹884.15, High: ₹900.3, Low: ₹874.5, 52 Week High: ₹1639, 52 Week Low: ₹726.8.
How to Buy Natco Pharma Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Natco Pharma Ltd shares
What are today's traded volumes of Natco Pharma Ltd?
Today's traded volume of Natco Pharma Ltd(NATCOPHARM) is 6.16L.
What is today's market capitalisation of Natco Pharma Ltd?
Today's market capitalisation of Natco Pharma Ltd(NATCOPHARM) is ₹13,889.97 Cr.
What is the 52 Week High and Low Range of Natco Pharma Ltd?
How much percentage Natco Pharma Ltd is down from its 52 Week High?
Natco Pharma Ltd (NATCOPHARM) share price is ₹883.3. It is down -46.11% from its 52 Week High price of ₹1639
How much percentage Natco Pharma Ltd is up from its 52 Week low?
Natco Pharma Ltd (NATCOPHARM) share price is ₹883.3. It is up 21.53% from its 52 Week Low price of ₹726.8